HSA — authorised 18 May 2000
- Marketing authorisation holder: SANDOZ
- Status: likely_approved
HSA authorised Infuvite Adult on 18 May 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 18 May 2000.
SANDOZ holds the Singaporean marketing authorisation.